Immunohistochemical Evaluation of RKI-1447 in Rat Thoracic Spinal Cord Compression Injury Model
DOI:
https://doi.org/10.70749/ijbr.v3i7.1841Keywords:
CNS Regeneration, Immunohistochemistry, Neuroprotection, Protein polymerization, GFAP, GAP-43, Neu N.Abstract
Background and Objectives: Compression spinal cord injury is a highly heterogeneous lesion, and tools to delineate pathophysiological recovery needed. Our objective was to profile the protective or reversal effects of RKI-1447 on neuron regeneration and its correlation with the degree of tissue damage in the rats with induced compression injury at the T7 level. Methodology: Albino rats of Sprague Dawley strain, 08 weeks of age, weighing 250 +10gm (n= 64) were used in this study. The animals were procured from the Animal House of Khyber Medical University, IBMS campus. Every experiment was carried out following a protocol that the Institutional Animal Ethics Committee authorized in 09.09.2020 under the (DIR / (KMU AS & RB/BD/001187) under the 89th meeting. The study duration was for 03 years, in which the histological studies took 06 months. Two groups of animals were formed. The experimental group and the control group (A). The experimental groups were further divided into four subgroups i.e. B, C and D. Group A was a sham group, in which rats were incised at level T7 only. Spinal cord compression injury at T7 level was performed in groups B, C and D. Group B was treated only with placebo while the group C and D, were treated with RKI-1447, with a dose of 0.3 and 0.6 µg/kg/b.w. respectively. For histological analysis, the animals were sacrificed 7, 14 and 28 days after the completion of behavioral studies. The staining pattern of glial fibrillary acidic protein (GFAP) for Astrocytosis/Reactive astrocytes, GAP-43, for Axonal growth/sprouting and Neu N for neuronal number for viability of neurons were observed. Results: All the group animals were evaluated daily after surgery. Consequently, our research showed that rats in group A healed quickly with just the Laminectomy procedure. In experimental rats, both groups C and D showed improved behavioral and histological results. In contrast, group B demonstrated sluggish and inadequate recovery. Additionally, group D rats showed superior performance in behavioral assessments, and their histological scores significantly surpassed those of group C. Group "D" excelled over group "C," probably because of the high dosage of RKI-1447 (0.6 µg/kg) administered to group D. Regarding the time-related effects of RKI-1447, the 28-day survival treatment yielded promising outcomes compared to the 14-days treatment. Conclusion: The current research presents evidence suggesting that both functional and morphological outcomes following spinal cord compression injury can progress in a discontinuous, non-linear fashion, despite the injury levels being graded in a linear manner. Serum levels of GFAP, GAP-43 and NeuN, may serve as potential biomarkers for assessing the severity of traumatic conditions and traumatic limb injuries. However, further animal studies are necessary to translate these findings into clinical applications.
Downloads
References
1. Chen Y, Tang Y, Vogel L, DeVivo M. Causes of spinal cord injury. Topics in spinal cord injury rehabilitation. 2013 Jan 1;19(1):1-8.
https://doi.org/10.1310/sci1901-1
2. Ahuja CS, Wilson JR, Nori S, Kotter M, Druschel C, Curt A, Fehlings MG. Traumatic spinal cord injury. Nature reviews Disease primers. 2017 Apr 27;3(1):1-21.
https://doi.org/10.1038/nrdp.2017.18
3. Budd MA, Gater Jr DR, Channell I. Psychosocial consequences of spinal cord injury: a narrative review. Journal of personalized medicine. 2022 Jul 20;12(7):1178.
https://doi.org/10.3390/jpm12071178
4. Yildiz KA, Shin AY, Kaufman KR. Interfaces with the peripheral nervous system for the control of a neuroprosthetic limb: a review. Journal of neuroengineering and rehabilitation. 2020 Mar 10;17(1):43.
https://doi.org/10.1186/s12984-020-00667-5
5. 1.Eng LF, et al. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 2000;25:1439–1451.
https://doi.org/10.1023/a:1007677003387
6. Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends in neurosciences. 2015 Jun 1;38(6):364-74.
https://doi.org/10.1016/j.tins.2015.04.003
7. Vitković L, Mersel M. Growth-associated protein 43 is down-regulated in cultured astrocytes. Metabolic brain disease. 1989 Mar;4(1):47-53.
https://doi.org/10.1007/bf00999493
8. Kawasaki A, Okada M, Tamada A, Okuda S, Nozumi M, Ito Y, Kobayashi D, Yamasaki T, Yokoyama R, Shibata T, Nishina H. Growth cone phosphoproteomics reveals that GAP-43 phosphorylated by JNK is a marker of axon growth and regeneration. Iscience. 2018 Jun 29;4:190-203.
https://doi.org/10.1016/j.isci.2018.05.019
9. Weyer A, Schilling K. Developmental and cell type‐specific expression of the neuronal marker NeuN in the murine cerebellum. Journal of neuroscience research. 2003 Aug 1;73(3):400-9.
https://doi.org/10.1002/jnr.10655
10. Collombet JM, Masqueliez C, Four E, Burckhart MF, Bernabé D, Baubichon D, Lallement G. Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neuroscience letters. 2006 May 8;398(3):337-42.
https://doi.org/10.1016/j.neulet.2006.01.029
11. Collombet JM, Masqueliez C, Four E, Burckhart MF, Bernabé D, Baubichon D, Lallement G. Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neuroscience letters. 2006 May 8;398(3):337-42.
12. Khan F, Baseer N, Habib SH, Khalid S. Effect Of Rki-1447 On The Behavioral Aspect Post Compression Injury Model In Rats. 2024 August;12: (5): 1743-52.
https://doi.org/10.53730/ijhs.v6ns9.14079
13. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Investigative ophthalmology & visual science. 1999 Oct 1;40(11):2481-9.
14. Suarez-Arnedo A, Figueroa FT, Clavijo C, Arbeláez P, Cruz JC, Muñoz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PloS one. 2020 Jul 28;15(7):e0232565.
https://doi.org/10.1371/journal.pone.0232565
15. Mumtaz S, Baseer N, Habib SH. Concomitant use of pre-emptive analgesia with local and general anesthesia in rat uterine pain surgical model. Molecular Pain. 2024 Apr 29;20:17448069241252385.
16. Wu S, Suzuki Y, Noda T, Bai H, Kitada M, Kataoka K, Nishimura Y, Ide C. Immunohistochemical and electron microscopic study of invasion and differentiation in spinal cord lesion of neural stem cells grafted through cerebrospinal fluid in rat. Journal of neuroscience research. 2002 Sep 15;69(6):940-5.
17. Kim SW, Roh J, Park CS. Immunohistochemistry for pathologists: protocols, pitfalls, and tips. Journal of pathology and translational medicine. 2016 Nov 15;50(6):411-8.
https://doi.org/10.4132/jptm.2016.08.08
18. Dang Y, Wang C, Shah P, Waxman S, Loewen RT, Loewen NA. RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis. Graefe's Archive for Clinical and Experimental Ophthalmology. 2019 Jan 28;257(1):101-9.
19. Wang Z, Higashikawa K, Yasui H, Kuge Y, Ohno Y, Kihara A, Midori YA, Houkin K, Kawabori M. FTY720 protects against ischemia–reperfusion injury by preventing the redistribution of tight junction proteins and decreases inflammation in the subacute phase in an experimental stroke model. Translational stroke research. 2020 Oct;11(5):1103-16.
https://doi.org/10.1007/s12975-020-00789-x
20. Patel RA, Forinash KD, Pireddu R, Sun Y, Sun N, Martin MP, Schönbrunn E, Lawrence NJ, Sebti SM. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer research. 2012 Oct 1;72(19):5025-34.
21. Ghobrial DK, El-Nikhely N, Sheta E, Ragab HM, Rostom SA, Saeed H, Wahid A. The role of pyrazolo [3, 4-d] pyrimidine-based kinase inhibitors in the attenuation of CCl4-induced liver fibrosis in rats. Antioxidants. 2023 Mar 3;12(3):637.
https://doi.org/10.3390/antiox12030637
22. Kang S, Liu S, Li H, Wang D, Qi X. Baicalin effects on rats with spinal cord injury by anti‐inflammatory and regulating the serum metabolic disorder. Journal of cellular biochemistry. 2018 Sep;119(9):7767-79.
23. Gu G, Ren J, Zhu B, Shi Z, Feng S, Wei Z. Multiple mechanisms of curcumin targeting spinal cord injury. Biomedicine & Pharmacotherapy. 2023 Mar 1;159:114224.
https://doi.org/10.1016/j.biopha.2023.114224
24. Chandran P, Chandramohan K, Iyer K, Michael FM, Seppan P, Venkatachalam S. Beneficial Effects of Ethanolic Extract of the Medicinal Herb Mucuna Pruriens Against Oxidative Stress and Inflammation Might be Limited in Contusive Spinal Cord Injury. Biomedical and Pharmacology Journal. 2022 Mar 31;15(1):235-48.
https://doi.org/10.13005/bpj/2359
25. Xiao S, Zhong N, Yang Q, Li A, Tong W, Zhang Y, Yao G, Wang S, Liu J, Liu Z. Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model. International Immunopharmacology. 2022 Oct 1;111:109163.
26. Kan S, Liu C, Zhao X, Feng S, Zhu H, Ma B, Zhou M, Fu X, Hu W, Zhu R. Resveratrol improves the prognosis of rats after spinal cord injury by inhibiting mitogen-activated protein kinases signaling pathway. Scientific reports. 2023 Nov 13;13(1):19723.
https://doi.org/10.1038/s41598-023-46541-x
27. Si L, An Y, Zhou J, Lai Y. Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms. Heliyon. 2025 Jan 15;11(1).
https://doi.org/10.1016/j.heliyon.2024.e41002
28. Damjanac M, Bilan AR, Barrier L, Pontcharraud R, Anne C, Hugon J, Page G. Fluoro-Jade® B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain research. 2007 Jan 12;1128:40-9.
https://doi.org/10.1016/j.brainres.2006.05.050
29. Wang C, Wang M, Xia K, Wang J, Cheng F, Shi K, Ying L, Yu C, Xu H, Xiao S, Liang C. A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioactive materials. 2021 Aug 1;6(8):2523-34.
https://doi.org/10.1016/j.bioactmat.2021.01.029
30. Jiang X, Yu X, Chen J, Jing C, Xu L, Chen Z, Liu F, Chen L. Ferulic acid improves motor function induced by spinal cord injury in rats via inhibiting neuroinflammation and apoptosis. Acta Cirúrgica Brasileira. 2021 Sep 3;36(7):e360705.
https://doi.org/10.1590/acb360705
31. Luo W, Wang Y, Lin F, Liu Y, Gu R, Liu W, Xiao C. Selenium-doped carbon quantum dots efficiently ameliorate secondary spinal cord injury via scavenging reactive oxygen species. International Journal of Nanomedicine. 2020 Dec 14:10113-25.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
